Coffee, Parkinson’s, and Alzheimer’s: What We Actually Know (and What We Don’t)

If you’ve ever heard “coffee is protective for the brain,” you’re not imagining it. Major health systems (including Mayo Clinic) have noted that coffee drinking is linked with a lower risk of certain conditions — including Parkinson’s disease, and in some research, Alzheimer’s disease/dementia.

(Mayo Clinic) But the internet often turns “linked with” into “prevents.” Let’s slow down and separate the solid from the speculative.

The headline claim: does coffee reduce Parkinson’s and Alzheimer’s?

Parkinson’s: the association is pretty consistent. Across many long-term cohort studies, people who consume caffeine (often via coffee) tend to have lower Parkinson’s risk than non-consumers. This finding has been replicated enough times that it’s become one of the more consistent diet–Parkinson’s signals we have.

Researchers also keep circling the same likely driver: caffeine. Mayo Clinic notes that some benefits of coffee are tied to caffeine, while others may come from coffee’s other compounds. (Mayo Clinic) More recent work has tried to get more precise by looking at caffeine biomarkers/metabolites (not just self-reported cups) and still finds patterns consistent with a protective association. (American Academy of Neurology)

Bottom line: If you’re looking for the stronger “coffee + brain” story, Parkinson’s is it.